GHSI Stock Summary and Trading Ideas (Guardion Health Sciences | NASDAQ:GHSI)

Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.

Guardion Health Sciences trades on the NASDAQ stock market under the symbol GHSI.

As of May 21, 2024, GHSI stock price climbed to $9.20 with 61,151 million shares trading.

GHSI has a beta of 0.84, meaning it tends to be less sensitive to market movements. GHSI has a correlation of 0.03 to the broad based SPY ETF.

GHSI has a market cap of $11.81 million. This is considered a Sub-Micro Cap stock.

Last quarter Guardion Health Sciences reported $3 million in Revenue and -$3.71 earnings per share. This fell short of revenue expectation by $-120,355 and missed earnings estimates by -$2.83.

In the last 3 years, GHSI stock traded as high as $99.00 and as low as $4.66.

The top ETF exchange traded funds that GHSI belongs to (by Net Assets): VXF, DFAT.

GHSI has outperformed the market in the last year with a price return of +39.4% while the SPY ETF gained +28.3%. GHSI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.4% and +15.0%, respectively, while the SPY returned +7.1% and +2.7%, respectively.

GHSI support price is $7.62 and resistance is $8.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GHSI stock will trade within this expected range on the day.